Sunshine Biopharma (SBFM)

$1.53 +0.02 (1.32%)
Market Cap 6.88M
Revenue (ttm) 34.87M
Net Income (ttm) -5.13M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -14.71%
Debt to Equity Ratio 0.00
Volume 36,700
Avg Vol 49,334
Day's Range N/A - N/A
Shares Out 4.56M
Stochastic %K 39%
Beta 1.48
Analysts Strong Sell
Price Target $7.00

Company Profile

Sunshine Biopharma, Inc. operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates through Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products segments. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pa...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: (954) 330-0684
Address:
333 Las Olas Way, CU4 Suite 433, Fort Lauderdale, United States
GovNewnormal
GovNewnormal Oct. 3 at 8:17 PM
$SBFM News on the generics should be coming in. And sales too. Earnings release is estimated to around Nov 2nd. Hoping for a surprise. (A good one.)
0 · Reply
stockanalyzer777
stockanalyzer777 Oct. 3 at 7:16 PM
$SBFM Management, Hurry up and release a good PR. We need one good PR to ignite a multi day run. The day I sell this stock would be the day it runs to $70.00 per share. My patience is running low but I am so hopeful.
1 · Reply
Sobo90
Sobo90 Oct. 3 at 2:56 PM
$SBFM no pipeline but still undervalued if Nora pharma alone was considered as a standalone company. I have no illusions that there is any real oncology work happening at this company.
1 · Reply
BullDurham22
BullDurham22 Oct. 3 at 2:23 PM
$SBFM You could have picked almost any random stock in the past 5 years and still come out better than SBFM. At best, you’d lose less — at worst, you’d actually make money. I’m closing my position the moment my tax-loss window opens. Don't get greedy trapped like I was!
1 · Reply
GovNewnormal
GovNewnormal Oct. 2 at 1:59 AM
$SBFM Yeah, I am adding back here. Finally after a long time. Just to get out of the pit. I needed reassurance that it was not going close to the dollar threshold again, where it could r/s again! Stability at the 1.45 - 1.50 range feels secure now. Now can they have a good earnings?
0 · Reply
DipnRiptrader
DipnRiptrader Oct. 2 at 12:16 AM
$SBFM adding back here. Unfortunately heavily manipulated
0 · Reply
Nuisance
Nuisance Oct. 1 at 4:35 PM
$SBFM 🙏🙏🙏
0 · Reply
stockanalyzer777
stockanalyzer777 Oct. 1 at 4:21 PM
$SBFM
0 · Reply
MB66
MB66 Sep. 30 at 11:24 PM
$SBFM CPA Firm has been dropped. That is all. https://sunshinebiopharma.com/wp-content/uploads/2025/09/20250930_Sunshine-Biopharma_8-K-3.pdf
2 · Reply
MxPw
MxPw Sep. 30 at 10:58 PM
$SBFM we need new management
2 · Reply
Latest News on SBFM
Sunshine Biopharma Launches NIOPEG(R) Into $10 Billion Biologics Market

Jul 2, 2025, 8:00 AM EDT - 3 months ago

Sunshine Biopharma Launches NIOPEG(R) Into $10 Billion Biologics Market

Sunshine Biopharma Launches Generic Gabapentin for Neuropathic Pain in the Canadian Segment of the Global $1.92 Billion Market

Jun 11, 2025, 8:30 AM EDT - 4 months ago

Sunshine Biopharma Launches Generic Gabapentin for Neuropathic Pain in the Canadian Segment of the Global $1.92 Billion Market

Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last Year

May 15, 2025, 4:15 PM EDT - 5 months ago

Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last Year

Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion Market

May 6, 2025, 8:30 AM EDT - 5 months ago

Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion Market

Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion

Apr 21, 2025, 8:30 AM EDT - 5 months ago

Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion

Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering

Apr 3, 2025, 10:50 AM EDT - 6 months ago

Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering

Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules

Apr 2, 2025, 1:20 PM EDT - 6 months ago

Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules

Sunshine Biopharma Stock Shoots Higher On Encouraging Data From mRNA-Based Liver Cancer Drug

Apr 2, 2025, 11:35 AM EDT - 6 months ago

Sunshine Biopharma Stock Shoots Higher On Encouraging Data From mRNA-Based Liver Cancer Drug

Sunshine Biopharma Announces Positive Results of mRNA Therapy for Cancer

Apr 2, 2025, 8:00 AM EDT - 6 months ago

Sunshine Biopharma Announces Positive Results of mRNA Therapy for Cancer

Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year

Apr 1, 2025, 5:09 PM EDT - 6 months ago

Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year

Sunshine Biopharma Expands Presence in the $53.9 Billion Global Antibiotics Market with the Acquisition of Marketing Rights for Two New Antibiotics in Canada

Mar 24, 2025, 8:00 AM EDT - 6 months ago

Sunshine Biopharma Expands Presence in the $53.9 Billion Global Antibiotics Market with the Acquisition of Marketing Rights for Two New Antibiotics in Canada

Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market

Mar 10, 2025, 9:00 AM EDT - 7 months ago

Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market

Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT

Jan 21, 2025, 8:00 AM EST - 9 months ago

Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT

Sunshine Biopharma Announces the Appointment of New Chief Commercial Officer

Jan 15, 2025, 8:00 AM EST - 9 months ago

Sunshine Biopharma Announces the Appointment of New Chief Commercial Officer

Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus

Dec 9, 2024, 7:30 AM EST - 10 months ago

Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus

Sunshine Biopharma Launches a New Generic Prescription Drug

Dec 4, 2024, 4:05 PM EST - 10 months ago

Sunshine Biopharma Launches a New Generic Prescription Drug

Sunshine Biopharma Announces Breakthrough Research Results on the Company's K1.1 mRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma

Dec 2, 2024, 8:00 AM EST - 10 months ago

Sunshine Biopharma Announces Breakthrough Research Results on the Company's K1.1 mRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma

Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54%

Nov 6, 2024, 8:00 AM EST - 11 months ago

Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54%

Sunshine Biopharma Launches Two New Generic Prescription Drugs

Sep 26, 2024, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Launches Two New Generic Prescription Drugs

Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry

Sep 4, 2024, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry

Sunshine Biopharma Has Launched Nine New Generic Prescription Drugs in 2024: Now Marketing Sixty-One Generic Drugs in Canada

Aug 26, 2024, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Has Launched Nine New Generic Prescription Drugs in 2024: Now Marketing Sixty-One Generic Drugs in Canada

Sunshine Biopharma Reports 2024 Second Quarter Results: Second QTR Revenues up 67%, YTD Revenues up 61%

Aug 19, 2024, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Reports 2024 Second Quarter Results: Second QTR Revenues up 67%, YTD Revenues up 61%

Sunshine Biopharma Announces Reverse Stock Split

Aug 6, 2024, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Announces Reverse Stock Split

Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R)

Apr 19, 2024, 8:00 AM EDT - 1 year ago

Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R)

Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023

Apr 1, 2024, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023

Sunshine Biopharma, Inc. Announces Closing of $10.0 Million Underwritten Public Offering

Feb 15, 2024, 9:15 AM EST - 1 year ago

Sunshine Biopharma, Inc. Announces Closing of $10.0 Million Underwritten Public Offering

Sunshine Biopharma, Inc. Announces Pricing of $10.0 Million Underwritten Public Offering

Feb 13, 2024, 9:00 AM EST - 1 year ago

Sunshine Biopharma, Inc. Announces Pricing of $10.0 Million Underwritten Public Offering

Sunshine Biopharma Moves Principal Office to New York City

Dec 4, 2023, 8:30 AM EST - 1 year ago

Sunshine Biopharma Moves Principal Office to New York City

Sunshine Biopharma Reports 2023 Third Quarter Results: Revenues up Significantly Over Last Year Due to a Key Acquisition

Nov 13, 2023, 8:30 AM EST - 2 years ago

Sunshine Biopharma Reports 2023 Third Quarter Results: Revenues up Significantly Over Last Year Due to a Key Acquisition

Sunshine Biopharma Receives 180-Day Extension To Achieve Nasdaq Minimum Bid Compliance

Sep 21, 2023, 9:05 PM EDT - 2 years ago

Sunshine Biopharma Receives 180-Day Extension To Achieve Nasdaq Minimum Bid Compliance

Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%

Aug 11, 2023, 8:30 AM EDT - 2 years ago

Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%

Aegis Capital Corp. Acted as Exclusive Placement Agent on a $5.0 Million Private Placement Priced At-the-Market for Sunshine Biopharma, Inc. (NASDAQ:SBFM)

May 16, 2023, 2:15 PM EDT - 2 years ago

Aegis Capital Corp. Acted as Exclusive Placement Agent on a $5.0 Million Private Placement Priced At-the-Market for Sunshine Biopharma, Inc. (NASDAQ:SBFM)

Sunshine Biopharma Announces Closing of $5.0 Million Private Placement Priced At-the-Market

May 16, 2023, 9:58 AM EDT - 2 years ago

Sunshine Biopharma Announces Closing of $5.0 Million Private Placement Priced At-the-Market

Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-Market

May 12, 2023, 8:00 AM EDT - 2 years ago

Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-Market

Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100%

May 11, 2023, 9:00 AM EDT - 2 years ago

Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100%

Sunshine Biopharma Reports Full Year Ended December 31, 2022 Financial Results and Provides Corporate Update

Apr 5, 2023, 8:00 AM EDT - 2 years ago

Sunshine Biopharma Reports Full Year Ended December 31, 2022 Financial Results and Provides Corporate Update

Sunshine Biopharma Signs Exclusive Worldwide License With University of Arizona For PLpro-Based Covid-19 Treatment

Feb 28, 2023, 7:30 AM EST - 2 years ago

Sunshine Biopharma Signs Exclusive Worldwide License With University of Arizona For PLpro-Based Covid-19 Treatment

Sunshine Biopharma Signs Research Agreement With the Jewish General Hospital to Advance the Development of Adva-27a Anticancer Compound

Feb 10, 2023, 7:35 AM EST - 2 years ago

Sunshine Biopharma Signs Research Agreement With the Jewish General Hospital to Advance the Development of Adva-27a Anticancer Compound

Sunshine Biopharma Announces Share Repurchase Program

Jan 19, 2023, 7:30 AM EST - 2 years ago

Sunshine Biopharma Announces Share Repurchase Program

Sunshine Biopharma's Annual Letter to Shareholders

Dec 20, 2022, 8:00 AM EST - 3 years ago

Sunshine Biopharma's Annual Letter to Shareholders

4 Stocks Meeting GuruFocus' Value Screens in December

Dec 5, 2022, 5:46 PM EST - 3 years ago

4 Stocks Meeting GuruFocus' Value Screens in December

RM CACC WFG

Sunshine Biopharma Enters Into a Collaboration Agreement with a Leading Lipid Nanoparticle Formulation Company for Its K1.1 Anticancer mRNA Project

Nov 16, 2022, 8:00 AM EST - 3 years ago

Sunshine Biopharma Enters Into a Collaboration Agreement with a Leading Lipid Nanoparticle Formulation Company for Its K1.1 Anticancer mRNA Project

Sunshine Biopharma Announces the Acquisition of Nora Pharma, Adding $10.7 Million in Revenue

Oct 20, 2022, 8:00 AM EDT - 3 years ago

Sunshine Biopharma Announces the Acquisition of Nora Pharma, Adding $10.7 Million in Revenue

Sunshine Biopharma Files Its Second Quarter Report With the SEC

Aug 4, 2022, 8:00 AM EDT - 3 years ago

Sunshine Biopharma Files Its Second Quarter Report With the SEC

Sunshine Biopharma Increases Support for Anti-Coronavirus Collaborative Research With the University of Arizona

Jul 28, 2022, 8:10 AM EDT - 3 years ago

Sunshine Biopharma Increases Support for Anti-Coronavirus Collaborative Research With the University of Arizona

Sunshine Biopharma: An Opportunity Knocking?

May 9, 2022, 11:03 AM EDT - 3 years ago

Sunshine Biopharma: An Opportunity Knocking?

Sunshine Biopharma, Inc. Announces Closing of $19.5 Million Private Placement Priced At-the-Market

Apr 28, 2022, 4:50 PM EDT - 3 years ago

Sunshine Biopharma, Inc. Announces Closing of $19.5 Million Private Placement Priced At-the-Market

Aegis Capital Corp. acted as Exclusive Placement Agent on a $19.5 Million Private Placement Priced At-the-Market for Sunshine Biopharma Inc. (NASDAQ: SBFM)

Apr 28, 2022, 9:20 AM EDT - 3 years ago

Aegis Capital Corp. acted as Exclusive Placement Agent on a $19.5 Million Private Placement Priced At-the-Market for Sunshine Biopharma Inc. (NASDAQ: SBFM)

Sunshine Biopharma, Inc. Announces Pricing of $19.5 Million Private Placement Priced At-the-Market

Apr 26, 2022, 12:41 AM EDT - 3 years ago

Sunshine Biopharma, Inc. Announces Pricing of $19.5 Million Private Placement Priced At-the-Market

Why Sunshine Biopharma Stock Is Surging

Apr 25, 2022, 10:57 AM EDT - 3 years ago

Why Sunshine Biopharma Stock Is Surging

GovNewnormal
GovNewnormal Oct. 3 at 8:17 PM
$SBFM News on the generics should be coming in. And sales too. Earnings release is estimated to around Nov 2nd. Hoping for a surprise. (A good one.)
0 · Reply
stockanalyzer777
stockanalyzer777 Oct. 3 at 7:16 PM
$SBFM Management, Hurry up and release a good PR. We need one good PR to ignite a multi day run. The day I sell this stock would be the day it runs to $70.00 per share. My patience is running low but I am so hopeful.
1 · Reply
Sobo90
Sobo90 Oct. 3 at 2:56 PM
$SBFM no pipeline but still undervalued if Nora pharma alone was considered as a standalone company. I have no illusions that there is any real oncology work happening at this company.
1 · Reply
BullDurham22
BullDurham22 Oct. 3 at 2:23 PM
$SBFM You could have picked almost any random stock in the past 5 years and still come out better than SBFM. At best, you’d lose less — at worst, you’d actually make money. I’m closing my position the moment my tax-loss window opens. Don't get greedy trapped like I was!
1 · Reply
GovNewnormal
GovNewnormal Oct. 2 at 1:59 AM
$SBFM Yeah, I am adding back here. Finally after a long time. Just to get out of the pit. I needed reassurance that it was not going close to the dollar threshold again, where it could r/s again! Stability at the 1.45 - 1.50 range feels secure now. Now can they have a good earnings?
0 · Reply
DipnRiptrader
DipnRiptrader Oct. 2 at 12:16 AM
$SBFM adding back here. Unfortunately heavily manipulated
0 · Reply
Nuisance
Nuisance Oct. 1 at 4:35 PM
$SBFM 🙏🙏🙏
0 · Reply
stockanalyzer777
stockanalyzer777 Oct. 1 at 4:21 PM
$SBFM
0 · Reply
MB66
MB66 Sep. 30 at 11:24 PM
$SBFM CPA Firm has been dropped. That is all. https://sunshinebiopharma.com/wp-content/uploads/2025/09/20250930_Sunshine-Biopharma_8-K-3.pdf
2 · Reply
MxPw
MxPw Sep. 30 at 10:58 PM
$SBFM we need new management
2 · Reply
Nuisance
Nuisance Sep. 30 at 8:02 PM
$SBFM 💪strong finish
0 · Reply
contra7
contra7 Sep. 30 at 4:09 PM
$SBFM $DRUG DRUG revenue is 0 Market Cap is 420 million Stock Price: $60 SBFM revenue is 35 million (2024) Market Cap is 6.65 million Stock Price $1.47 (UNDERVALUED)
1 · Reply
stockanalyzer777
stockanalyzer777 Sep. 29 at 10:44 PM
$SBFM $SBFM has been silent for 3 months. I pray the next PR causes an influx of buying pressure where the stock price settles no less than $70.00 per share. Let $SBFM BE THE NEXT $NUKK , $DRUG or other stocks that ran 8000 %. Hopefully October is our month.
3 · Reply
Nuisance
Nuisance Sep. 29 at 3:48 PM
$SBFM 📈
0 · Reply
supsupsup
supsupsup Sep. 29 at 5:00 AM
$SBFM
1 · Reply
stockanalyzer777
stockanalyzer777 Sep. 28 at 7:32 PM
$SBFM I plan to buy additional 3000 shares tomorrow. This baby will reach >$15.00 per share sooner than later. I am hoping >$70 Per share. $SBFM SO-4.456 million SF-4.55 million The company has 17.7 months of cash left per their quarterly spending Price target> LIMITLESS LET'S GO BULLS!!!!!!
1 · Reply
Jdneri1
Jdneri1 Sep. 26 at 9:23 PM
$SBFM its time to pick the harvest, something big is coming
0 · Reply
Suomalainen
Suomalainen Sep. 26 at 7:55 PM
$SBFM Could SBFM be importing generics without the 100% tariffs to US starting Oct. 1st ?
1 · Reply
alert716
alert716 Sep. 26 at 5:12 PM
$SBFM add this on long term swing if you missed my $INDP alert that did over 150% in less than 24 hours 🤑🤑🤑
0 · Reply
alert716
alert716 Sep. 26 at 5:06 PM
$SBFM adding on a long swing 🤑🤑🤑🤑
0 · Reply
contra7
contra7 Sep. 25 at 9:47 PM
$SBFM Has launched 6 new generic prescription drugs in 2025 including their wholly owned oncology cash cow Niopeg which became available at the start of Q3. They are launching 12 more new generic drugs before year end which will bring the total to 84. Hopefully some of these high value generics are announced.
0 · Reply
William_H_Bonney
William_H_Bonney Sep. 25 at 9:43 AM
$SBFM nervous about the recent gains?
2 · Reply